1) bulk degradation
本体降解
2) degradation in vitro
体外降解
1.
In this paper,the effect of polymerization condition on intrinsic viscosity( η ) of polydioxanone and conversion for the polymerization of dioxanone was investigated, and the hydrolytic degradation in vitro of polydioxanone suture was studied.
研究了合成条件对聚对二氧杂环己酮特性粘度和转化率的影响，及其由聚合物制作的缝线的体外降解性能。
3) in vitro degradation
体外降解
1.
Study on the in vitro degradation of poly(propylene fumarate)/(calcium sulfate/β-tricalcium phosphate) biocomposites
聚富马酸丙二醇酯/(硫酸钙/β-磷酸三钙)生物复合材料的体外降解研究
2.
Properties of polyglycolic acid fiber in vitro degradation
聚乙交酯纤维的体外降解性能
3.
The in vitro degradation of the crosslinked composites formed by unsaturated polyphosphoester(UPPE)、N-vinyl pyrrolidone(NVP) and β-tricalcium phosphate(β-TCP) was investigated and the surface morphology of dagradation sample was imaged by scanning electron microscopy(SEM).
研究了不饱和聚磷酸酯(UPPE)、N-乙烯基吡咯烷酮(NVP)与β-磷酸钙(β-TCP)交联复合体系的体外降解过程,并用扫描电镜观察了降解一定时间后试样表面的形貌结构。
4) vitro degradation
体外降解
1.
Research on in vitro degradation of β-TCP/PLLA internal fracture fixation composite material;
β-磷酸三钙/聚左旋乳酸骨折内固定材料的体外降解性能研究
6) degradation
[英][,deɡrə'deɪʃn] [美]['dɛgrə'deʃən]
体外降解
1.
To select the best scale of β-TCP toβ-TCP /PDLLA by the degradation experiment in vitro;
体外降解实验筛选骨修复材料β-TCP/DLPLA最适比例
2.
Preparation, Degradation and Cytocompatibility of Poly-L-lactic Acid (PLLA) Scaffold for Cartilage Tissue Engineering;
本文以聚-L-乳酸(PLLA)为原料,研究了多孔支架的制备、体外降解和软骨细胞的相容性。
补充资料：可降解淀粉微球和生物降解白蛋白微球阻滞法
可降解淀粉微球和生物降解白蛋白微球阻滞法
介入放射学技术。介入性局部化疗之前，把二者注入靶动脉，可暂时减少动脉血流，再行化疗药物灌注，以减少血液冲刷，保持局部化疗药物浓度的技术。与其他中期和长期栓塞微球不同，DSM和BAM仅造成数十分钟的血流量减少，待其被降解后血流可恢复至以前水平。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条